Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.96
-0.31 (-4.26%)
At close: May 18, 2026, 4:00 PM EDT
6.96
0.00 (0.00%)
After-hours: May 18, 2026, 4:10 PM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $179.58 million as of May 18, 2026. Its market cap has increased by 197.59% in one year.
Market Cap
179.58M
Enterprise Value
102.74M
1-Year Change
197.59%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $179.58M, a decrease of -79.00%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 187.58M | 87.32% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 204.56M |
| Context Therapeutics | 198.46M |
| Corbus Pharmaceuticals Holdings | 195.63M |
| Elicio Therapeutics | 195.55M |
| Innate Pharma | 189.73M |
| Nkarta | 188.88M |
| Oramed Pharmaceuticals | 187.67M |
| Tenaya Therapeutics | 186.03M |